ACUTAAS CHEMICALS LIMITED Fair Value
ACUTAAS · Healthcare · Current price ₹3,619.4
| Method | Fair value | Status |
|---|---|---|
| Residual income | ₹345 | 24% ROE fading to 12% over ~10 yrs, on ₹202 book |
| Relative P/E | ₹1,702 | EPS × 39.1 peer-median P/E |
| Graham floor | ₹445 | Conservative floor: √(22.5 × EPS × book value/share) |
| Analyst target | — | No analyst coverage |
Is ACUTAAS CHEMICALS LIMITED undervalued?
DocStoX estimates the fair value of ACUTAAS CHEMICALS LIMITED at ₹742 per share, versus the current market price of ₹3,619. That puts the stock about -79.5% above our fair-value estimate, which we read as "Avoid". Our confidence in this estimate is low.
How this fair value is calculated
This estimate blends 3 independent methods: Residual income (₹345), Relative P/E (₹1,702), Graham floor (₹445). We weight each by its reliability and skip any method whose inputs look untrustworthy — "no DCF beats a wrong DCF". This is the same deterministic engine that powers DocStoX stock pages; there is no guesswork or AI-generated number here.
Bear, base and bull scenarios
Our scenarios span ₹345 (bear) to ₹742 (base) to ₹1,702 (bull). A margin of safety means buying meaningfully below the base case — the wider the gap, the more room for error in the assumptions.
More on ACUTAAS CHEMICALS LIMITED
DocStoX estimates are generated by a deterministic valuation engine from reported financials — for informational purposes only, not investment advice. Consult a SEBI-registered advisor before investing.